Default: Nuclear Medicine and Molecular Imaging

ISSN: 1869-3474

Journal Home

Journal Guideline

Nuclear Medicine and Molecular Imaging Q2 Unclaimed

Springer Verlag Germany
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Nuclear Medicine and Molecular Imaging is a journal indexed in SJR in Radiology, Nuclear Medicine and Imaging with an H index of 35. It has a price of 2690 €. It has an SJR impact factor of 0,517 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,517.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Price

2690 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Nuclear Medicine and Molecular Imaging

0,517

SJR Impact factor

35

H Index

67

Total Docs (Last Year)

142

Total Docs (3 years)

1978

Total Refs

240

Total Cites (3 years)

128

Citable Docs (3 years)

2

Cites/Doc (2 years)

29.52

Ref/Doc

Comments

No comments ... Be the first to comment!



Best articles by citations

Current Methods to Define Metabolic Tumor Volume in Positron Emission Tomography: Which One is Better?

View more

Kikuchi Disease Mimicking Metastatic Lymphadenopathy on 18F-FDG PET/CT in Patients with Breast Cancer

View more

Comparison of the Intraperitoneal, Retroorbital and per Oral Routes for F-18 FDG Administration as Effective Alternatives to Intravenous Administration in Mouse Tumor Models Using Small Animal PET/CT Studies

View more

NaF18-PET/CT Imaging of Secondary Hyperparathyroidism

View more

Renal Metastasis from Follicular Thyroid Carcinoma Diagnosed by I-131 Whole-body Scan Mimicking Renal Cell Carcinoma on Contrast-Enhanced Computed Tomography

View more

Dual Tracer PET Imaging with FDG and FLT Differentiates Tuberculous Lymphadenopathy from Metastases in a Case of Carcinoma Cervix

View more

Brain Metastasis from Neuroblastoma Depicted by 18F-DOPA PET/CT

View more

Does 131I Radioactivity Interfere with Thyroglobulin Measurement in Patients Undergoing Radioactive Iodine Therapy with Recombinant Human TSH?

View more

Visual Pattern and Serial Quantitation of 18F-Sodium Fluoride PET/CT in Asymptomatic Patients After Hip and Knee Arthroplasty

View more

Incidental Diagnosis of Carcinoma of the Bladder Due to Uptake of 99mTc-MDP

View more

Whole-Body Bone Scan Findings after High-Intensity Focused Ultrasound (HIFU) Treatment

View more

Molecular Imaging of Biological Gene Delivery Vehicles for Targeted Cancer Therapy: Beyond Viral Vectors

View more
SHOW MORE ARTICLES

Autoclustering of Non-small Cell Lung Carcinoma Subtypes on 18F-FDG PET Using Texture Analysis: A Preliminary Result

View more

Postoperative Functional Outcome After Off-Pump Versus On-Pump Coronary Artery Bypass Grafting Using Gated Myocardial SPECT: A Comparison by Propensity Score Analysis

View more

Orbital Metastases as Presenting Sign of Lung Carcinoma: Detection of Primary Malignancy and Disease Burden by F-18 FDG PET/CT

View more

Assessment of Therapeutic Effect of Sunitinib by 11C-Acetate PET Compared with FDG PET Imaging in a Patient with Metastatic Renal Cell Carcinoma

View more

Promotion of Nuclear Medicine-Related Sciences in Developing Countries

View more

Incidental Hiatal Hernia Detected with Meckel's Scintigraphy

View more

FDG-PET/CT in a Patient with Poor-Risk Non-Seminoma Testis with Mature Teratoma and Secondary Gliosarcoma: Multimodality Imaging for Guiding Multimodality Treatment

View more

Assessment of Therapy Response by 18F-FDG PET/CT for a Patient with Cutaneous and Subcutaneous Mycobacterium Infection and Coexisting Lymphoma

View more

Factors Associated with Diffusely Increased Splenic F-18 FDG Uptake in Patients with Cholangiocarcinoma

View more

Message from the President of the Korean Society of Nuclear Medicine

View more

Pixelized Measurement of 99mTc-HDP Micro Particles Formed in Gamma Correction Phantom Pinhole Scan: a Reference Study

View more

Correlation of Primary Tumor FDG Uptake with Clinicopathologic Prognostic Factors in Invasive Ductal Carcinoma of the Breast

View more

FAQS